Celyad Oncology
Board
10 directors, 1 in day-to-day management, 2 auditors, last change in January 2026Chair of the board and director, permanent representative
Director
current term since 05-05-2020
term until 20-05-2027
also on the board of 2 other companies
listed in the 2025 annual accounts, filed on 10-06-2026
1 other company bankruptDirector, permanent representative
since 05-05-2020
term until 20-05-2027
also on the board of 8 other companies
listed in the 2025 annual accounts, filed on 10-06-2026
1 other company bankruptDirector
since 17-12-2020
2-year term from 2025
listed in the 2025 annual accounts, filed on 10-06-2026
Director
since 13-01-2022
term until 20-05-2027
listed in the 2025 annual accounts, filed on 10-06-2026
Daily management delegate and director general, permanent representative
appointed by deed of 29-12-2025
Show all 13 office holders
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Two directors jointly, or a managing director alonedeed of 06-06-2019
Permanent representatives 4
Permanent representative, for
Mandates through the years
13 names, the dashed line is todayDirector
Non-executive director
Director, Chair of the board
Director
Director
Director
Director
Director
Director
Director
Daily management delegate and director general
Statutory auditor
Statutory auditor
LeadershipBoardEarlierRest of the term
Mandates as a list
-
- Director, appointed by deed of 20-01-2009, still in office
-
- Non-executive director, appointed by deed of 25-03-2015, until 09-11-2018
- Non-executive director, appointed by deed of 25-03-2015, still in office
-
- Director, from 01-06-2018 to date
- Chair of the board, appointed by deed of 11-01-2024, still in office
-
- Director, from 05-05-2020 to date
-
- Director, from 17-12-2020 to date
-
- Director, from 13-01-2022 to date
-
- Director, appointed by deed of 11-01-2024, still in office
-
- Director, from 14-11-2023 to date
-
- Director, from 14-11-2023 to date
-
- Director, from 16-09-2025 to date
-
- Daily management delegate and director general, appointed by deed of 29-12-2025, still in office
-
- Statutory auditor, appointed by deed of 30-06-2017, still in office
-
- Statutory auditor, from 05-05-2023 to date
With Starter you also see 34 former office holders in the mandate history.
See the plans →
Control
Parent
US
26,191,987 voting rights
58.51%
This company
Celyad Oncology
Equity €2.2m
Loss €564,911 in 2025
Capital
- Capital
- €9,716,154.53
- Shares
- 47,261,905
- Contribution per share
- €0.21
- Equity per share
- €0.05 in 2025
- Source
- deed of 31-07-2026
Owners through the years
as the annual accounts name themOwners as a list
-
- 2014: 35.11%
- 2015: 29.27%
- 2016: 24.35%
- 2017: 24.29%
- 2018: 23.25%
- 2019: 19.22%
- 2020: 16.47%
- 2021: 15.3%
- 2022: 10.16%
- 2023 to 2024: 12.93%
- 2025: 9.4%
-
- 2017: listed
-
- 2013 to 2014: 9.01%
- 2015: 6.76%
- 2016: 4.6%
Source: shareholder structure in its own accounts, lists of holdings in the owners' accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 06-06-2019 (in French)
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 3 directorsdeed of 09-06-2021 (in French)
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- 11 terdeed of 20-01-2009 (in French)
- Authorised capitalThe board may raise the capital up to this amount without a new shareholder decision.
- Premier et deuxième alinéas de la présente résolution, publication aux Annexes du Moniteur belge de la décision relative aux pouvoirs nouvellement octroyésdeed of 02-08-2017 (in French)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- 20 May at 15:00deed of 05-12-2024 (in French)
Shareholders
2 ownersOwners 2
- USparentSourceown accounts 202558.51%
- Equity €65.7m Loss of €461,234 in 2025 (loss of €6.5m in 2024) Checked score9.4%
Capital transactions
Shareholders according to the deeds
After the capital increase
deed of 07-09-2017 ↗
- €10,620,250
After the capital increase
deed of 13-02-2015 ↗
- in kind
After the capital increase
deed of 22-07-2014 ↗
- 284,090 shares
After the capital increase
deed of 09-07-2014 ↗
After 7 capital increases
deed of 01-12-2010 ↗
- 14,226 shares · €1,547,282.88 in cash
- 7,095 shares · €542,210.24 in cash
- in cash
- €3,069,911 in kind
- €325,312
- 5,678 shares · €298,509.12
- 1,500 shares · €271,034.40
- 7,101 shares · €108,555.20
- 5,676 shares · €74,149.92
- €52,474.24
- 1,018 shares · €35,996.48
- 5,682 shares · €200,915.52
- 5,676 shares · €200,703.36
- 3,549 shares · €125,492.64
- 2,412 shares · €85,288.32
- 3,393 shares
- 2,493 shares
- 900 shares
- 2,262 shares
At incorporation
deed of 06-08-2007 ↗
- 116,569 shares (28.5%)
- 126,193 shares (30.8%)
- 166,613 shares (40.7%)
Capital over time
- 31-07-2026 Capital increase of €500,000 · to €9,716,154.53 · 2,500,000 new shares at €0.20 per share, 5.3% of the 47,261,905 shares after the increase · in cash
- 21-08-2025 Capital increase of €999,999.90 · to €9,216,154.53 · 3,333,333 new shares at €0.30 per share · in cash
- 13-05-2024 Capital reduction of €24,732,646.07 · to €8,216,154.63 · to absorb losses
- 29-12-2023 Capital reduction of €55,429,423.55 · to €32,948,800.70 · to absorb losses
- 20-12-2023 Capital increase of €7,749,999.92 · to €88,378,224.25 · 14,903,846 new shares at €0.52 per share, 36% of the 41,428,572 shares after the increase · in cash
- 11-09-2023 Capital increase of €2,044,000 · to €80,628,224.33 · 3,930,770 new shares at €0.52 per share, 14.8% of the 26,524,726 shares after the increase · in cash
- 29-12-2021 Capital increase of €22,620,000 · to €78,584,224.33 · 6,500,000 new shares · in cash
- 18-11-2021 Capital increase of €1,014,000 · to €55,964,224.33 · 300,000 new shares at €3.38 per share · in cash
Show 48 older capital entries
- 03-09-2021 Capital increase of €1,038,000 · to €54,950,224.33 · 300,000 new shares at €3.46 per share · in cash
- 23-08-2021 Capital increase of €1,044,000 · to €53,912,224.33 · 300,000 new shares
- 25-06-2021 Capital increase of €23,664 · to €52,868,224.33 · 6,800 new shares
- 31-05-2021 Capital increase of €633,360 · to €52,844,560.33
- 07-05-2021 Capital increase of €1,044,000 · to €52,211,200.33 · 300,000 new shares · in cash
- 15-04-2021 Capital increase of €1,044,000 · to €51,167,200.33 · 300,000 new shares
- 02-04-2021 Capital increase of €696,000 · to €50,123,200.33 · 200,000 new shares · in cash
- 20-01-2021 Capital increase of €914,585.76 · to €49,427,200.33 · 262,812 new shares · in cash
- 07-10-2020 Capital increase of €9,666,663.96 · to €58,179,278.53 · in cash
- 02-10-2019 Capital increase · 2,000,000 new shares at €9.08 per share
- 19-09-2019 Capital increase of €16,008,000 · to €57,560,614.57 · in cash
- 06-06-2019 Capital stated in the deed · €41,552,614.57 · 11,942,344 shares
- 25-05-2018 Capital increase of €7,203,600 · 2,070,000 new shares
- 24-05-2018 Capital increase of €7,308,000 · to €41,657,014.57 · in cash
- 28-02-2018 Capital increase of €11,880 · to €34,349,014.57 · 4,500 new shares at €2.64 per share · in cash
- 04-12-2017 Capital increase of €43,821.76 · to €34,337,134.57 · 5,866 new shares · “création de 5.866 nouvelles actions jouissant des mêmes droits et avantages que les actions existantes”
- 07-09-2017 Capital increase · 328,275 new shares · “apport d'une créance certaine,liquide et exigible”
- 25-08-2017 Capital increase of €20,988 · to €33,151,900.63 · 7,950 new shares at €2.64 per share
- 22-05-2017 Capital increase of €12,936 · to €33,130,912.63 · 4,900 new shares at €2.64 per share, 0.1% of the 9,525,753 shares after the increase
- 21-02-2017 Capital increase of €547,140 · to €33,117,976.63 · 207,250 new shares at €2.64 per share, 2.2% of the 9,520,853 shares after the increase · in cash
- 04-09-2015 Capital increase · to €32,570,836.63 · 5,916 new shares · in cash
- 15-07-2015 Capital increase · to €32,550,130.63
- 02-06-2015 Capital increase of €1,750 · to €27,440,130.63 · 500 new shares
- 25-03-2015 Capital increase of €2,496,830 · to €27,438,380.63
- 26-02-2015 Capital increase of €1,165.50 · to €24,941,550.63 · 333 new shares · in cash
- 13-02-2015 Capital increase of €325,804.50 · to €24,940,385.13 · 93,087 new shares, 1.3% of the 7,133,474 shares after the increase · in kind
- 28-11-2014 Capital increase of €17,500 · to €24,614,580.63 · 5,000 new shares
- 25-08-2014 Capital increase of €20,125 · to €24,597,080.63 · 5,750 new shares · in cash
- 22-07-2014 Capital increase · 284,090 new shares
- 09-07-2014 Capital increase of €12,499,960 · 284,090 new shares at €44 per share · in cash
- 05-06-2014 Capital increase · to €22,588,325.63 · 6,461,457 new shares
- 21-02-2014 Capital increase of €442,046.50 · to €22,580,054.43
- 16-08-2013 Capital increase · to €22,138,007.93
- 26-07-2013 Capital increase of €4,835,250 · to €21,412,720.43 · 1,381,500 new shares, 22.6% of the 6,125,567 shares after the increase
- 24-06-2013 Capital increase of €24,091.76 · to €16,577,470.43 · 2,409,176 new shares at €0.01 per share · in cash
- 20-06-2013 Capital increase of €1,552,729.26 · to €16,553,378.67 · 219,016 new shares
- 05-06-2013 Capital increase of €5,026,142 · to €15,000,649.41 · 905,357 new shares
- 05-06-2013 Capital increase of €24,336.18
- 21-03-2013 Capital increase of €632,800
- 06-06-2011 Capital reduction of €18,925,474.35 · to €9,974,507.41 · to absorb losses
- 01-12-2010 Capital increase of €471,240 · to €17,270,414.52 · 21,000 new shares at €22.44 per share · in cash
- 01-12-2010 Capital increase of €3,069,911 · to €20,340,325.52 · 69,455 new shares at €44.20 per share · in kind
- 01-12-2010 Capital increase of €5,274,403.68 · to €25,614,729.20 · 149,163 new shares at €35.36 per share · in kind
- 01-12-2010 Capital increase of €2,018,879.20 · 57,095 new shares at €35.36 per share
- 01-12-2010 Capital increase of €2,609,320.48 · to €28,224,049.68 · 73,793 new shares at €35.36 per share · in cash
- 01-12-2010 Capital increase of €399,921.60 · to €28,623,971.28 · 9,048 new shares at €44.20 per share · in cash
- 01-12-2010 Capital increase of €276,012 · to €28,899,983.28
- 06-08-2007 Incorporation · €62,500 · 409,375 shares
The directors' other companies
3 current directors with another company that went bankrupt, was dissolved or struck off1 other company of this director went bankrupt (2026).
- bankruptcy on 22-10-2026appointed in 2014, in office until the bankruptcy
1 other company of this director went bankrupt (2026).
- bankruptcy on 20-04-2026mandate 2010 to 2022
1 other company of this director went bankrupt (2026).
- bankruptcy on 20-04-2026appointed in 2014, in office until the bankruptcy
Source: Belgian Official Gazette (bankruptcies, judicial dissolutions, board mandates), FPS Economy (strike-offs) and the KBO register. A bankruptcy, dissolution or strike-off says nothing about the director's part in it.